AssetMark Inc’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-9,839
Closed -$977K 1524
2019
Q3
$977K Buy
9,839
+5,366
+120% +$510K 0.01% 316
2019
Q2
$413K Sell
4,473
-790
-15% -$75K ﹤0.01% 379
2019
Q1
$497K Sell
5,263
-1,040
-17% -$91K ﹤0.01% 345
2018
Q4
$404K Buy
6,303
+81
+1% +$5.98K ﹤0.01% 362
2018
Q3
$557K Buy
6,222
+165
+3% +$14.6K 0.01% 342
2018
Q2
$481K Sell
6,057
-973
-14% -$80.8K ﹤0.01% 354
2018
Q1
$627K Sell
7,030
-3,595
-34% -$345K 0.01% 327
2017
Q4
$1.11M Buy
10,625
+1,215
+13% +$137K 0.01% 292
2017
Q3
$1.37M Sell
9,410
-424
-4% -$57.8K 0.02% 274
2017
Q2
$1.28M Buy
9,834
+593
+6% +$72.7K 0.02% 271
2017
Q1
$1.15M Sell
9,241
-722
-7% -$86.4K 0.02% 277
2016
Q4
$1.15M Sell
9,963
-582
-6% -$64.8K 0.02% 255
2016
Q3
$1.1M Sell
10,545
-202
-2% -$21.9K 0.02% 249
2016
Q2
$1.06M Sell
10,747
-5,325
-33% -$551K 0.02% 259
2016
Q1
$1.61M Sell
16,072
-1,211
-7% -$125K 0.03% 231
2015
Q4
$2.07M Buy
17,283
+16,567
+2,314% +$1.92M 0.04% 211
2015
Q3
$77K Buy
716
+445
+164% +$55.2K ﹤0.01% 362
2015
Q2
$31K Buy
+271
New +$31K ﹤0.01% 441

Other funds holding CELG

AssetMark Inc's CELG Position: Q4 2019 in Review

AssetMark Inc sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,839 shares — an estimated $977K sold.

AssetMark Inc first reported a position in CELG in Q2 2015 and held it in 18 quarters. The position peaked at $2.07M in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • AssetMark Inc reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • AssetMark Inc sold 9,839 Celgene Corp shares in Q4 2019, an estimated $977K.
  • AssetMark Inc first reported a position in Celgene Corp in Q2 2015 and held it in 18 quarters.
  • AssetMark Inc's Celgene Corp position peaked at $2.07M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on AssetMark Inc's 13F filing for Q4 2019, filed 11 Feb 2020.